Pancreatic Cancer Research

ResearcherUniversität UlmActive in the last 2 years

Thomas Wirth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4539-9054; OpenAlex author ID A5067802277, A5102710721. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 4

  1. NF-κB inducing kinase (NIK) deletion accelerates KRAS-driven pancreatic cancer in association with tumor microenvironment remodeling. Last author DOI 10.1038/s41419-026-08877-w↗
  2. Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. Co-author DOI 10.1038/s41420-026-03174-z↗
  3. NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer. Last author DOI 10.1186/s12943-024-01989-x↗
  4. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/ijms21155486↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Miltiadis Tsesmelis · 3 shared papers, 2020–2026 · strength 0.65
  2. Nadine Sperb · 2 shared papers, 2020–2024 · strength 0.38
  3. Ziwei Du · 1 shared paper, 2026 · strength 0.27
  4. Ali M. Kassem · 1 shared paper, 2026 · strength 0.24
  5. Hend Abdelrasoul · 1 shared paper, 2026 · strength 0.24
  6. Nuh N. Rahbari · 1 shared paper, 2026 · strength 0.24
  7. Bo Kong · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.